RE:RE:RE:FDAI have a large position and continue to accumulate on the pullbacks (if there is a spike, I sell some into it, although its just to offset costs on my buys) My analysis is that A) FDA on efficacy will be approved - based on all the positive data being published (whitepapers) and its non-invasiveness
B) They will own and lead a very large, untapped market worth multiple billions per annum C) the company's market cap is under $200MM - cheap in this space, so close to FDA approval
D) US military's $37MM collaboration - end result will be a large order upon FDA approval.
As this company nears the FDA approval timeline, the stock tightens and goes up in value. That is why it's now trading over the $2 range. With approx 80MM shares out (fully diluted) there is not a lot of volume, yet the stock is firm. This tells me there is a strong "wait for FDA" sentiment out there because of the massive upside on value.